{
  "DOI": "10.1007/s00439-016-1647-9",
  "ISSN": [
    "0340-6717",
    "1432-1203"
  ],
  "URL": "http://dx.doi.org/10.1007/s00439-016-1647-9",
  "alternative-id": [
    "1647"
  ],
  "assertion": [
    {
      "group": {
        "label": "Article History",
        "name": "ArticleHistory"
      },
      "label": "Received",
      "name": "received",
      "order": 1,
      "value": "29 October 2015"
    },
    {
      "group": {
        "label": "Article History",
        "name": "ArticleHistory"
      },
      "label": "Accepted",
      "name": "accepted",
      "order": 2,
      "value": "7 January 2016"
    },
    {
      "group": {
        "label": "Article History",
        "name": "ArticleHistory"
      },
      "label": "First Online",
      "name": "first_online",
      "order": 3,
      "value": "5 March 2016"
    },
    {
      "group": {
        "label": "Compliance with ethical standards",
        "name": "EthicsHeading"
      },
      "name": "Ethics",
      "order": 1
    },
    {
      "group": {
        "label": "Funding",
        "name": "EthicsHeading"
      },
      "name": "Ethics",
      "order": 2,
      "value": "FWA is supported by a Dekker scholarship-Junior Staff Member 2014T001—Netherlands Heart Foundation. The research leading to these results has received funding from the European Union Seventh Framework Programme FP7/2007-2013 under grant agreement n° HEALTH-F2-2013-601456 (CVgenes-at-target)."
    },
    {
      "group": {
        "label": "Conflict of interest",
        "name": "EthicsHeading"
      },
      "name": "Ethics",
      "order": 3,
      "value": "DIS is a consultant to Pfizer."
    }
  ],
  "author": [
    {
      "affiliation": [],
      "family": "Tragante",
      "given": "Vinicius",
      "sequence": "first"
    },
    {
      "affiliation": [],
      "family": "Asselbergs",
      "given": "Folkert W.",
      "sequence": "additional"
    },
    {
      "affiliation": [],
      "family": "Swerdlow",
      "given": "Daniel I.",
      "sequence": "additional"
    },
    {
      "affiliation": [],
      "family": "Palmer",
      "given": "Tom M.",
      "sequence": "additional"
    },
    {
      "affiliation": [],
      "family": "Moore",
      "given": "Jason H.",
      "sequence": "additional"
    },
    {
      "affiliation": [],
      "family": "de Bakker",
      "given": "Paul I. W.",
      "sequence": "additional"
    },
    {
      "affiliation": [],
      "family": "Keating",
      "given": "Brendan J.",
      "sequence": "additional"
    },
    {
      "ORCID": "http://orcid.org/0000-0001-6617-0879",
      "affiliation": [],
      "authenticated-orcid": false,
      "family": "Holmes",
      "given": "Michael V.",
      "sequence": "additional"
    }
  ],
  "container-title": [
    "Human Genetics"
  ],
  "content-domain": {
    "crossmark-restriction": false,
    "domain": [
      "link.springer.com"
    ]
  },
  "created": {
    "date-parts": [
      [
        2016,
        3,
        5
      ]
    ],
    "date-time": "2016-03-05T07:06:48Z",
    "timestamp": 1457161608000
  },
  "deposited": {
    "date-parts": [
      [
        2020,
        8,
        11
      ]
    ],
    "date-time": "2020-08-11T15:07:49Z",
    "timestamp": 1597158469000
  },
  "funder": [
    {
      "award": [
        "2014T001"
      ],
      "name": "Netherlands Heart Foundation"
    },
    {
      "award": [
        "2014T001"
      ],
      "name": "CVgenes@target"
    }
  ],
  "indexed": {
    "date-parts": [
      [
        2024,
        1,
        27
      ]
    ],
    "date-time": "2024-01-27T08:04:00Z",
    "timestamp": 1706342640452
  },
  "is-referenced-by-count": 12,
  "issn-type": [
    {
      "type": "print",
      "value": "0340-6717"
    },
    {
      "type": "electronic",
      "value": "1432-1203"
    }
  ],
  "issue": "5",
  "issued": {
    "date-parts": [
      [
        2016,
        3,
        5
      ]
    ]
  },
  "journal-issue": {
    "issue": "5",
    "published-print": {
      "date-parts": [
        [
          2016,
          5
        ]
      ]
    }
  },
  "language": "en",
  "license": [
    {
      "URL": "https://creativecommons.org/licenses/by/4.0",
      "content-version": "tdm",
      "delay-in-days": 0,
      "start": {
        "date-parts": [
          [
            2016,
            3,
            5
          ]
        ],
        "date-time": "2016-03-05T00:00:00Z",
        "timestamp": 1457136000000
      }
    },
    {
      "URL": "https://creativecommons.org/licenses/by/4.0",
      "content-version": "vor",
      "delay-in-days": 0,
      "start": {
        "date-parts": [
          [
            2016,
            3,
            5
          ]
        ],
        "date-time": "2016-03-05T00:00:00Z",
        "timestamp": 1457136000000
      }
    }
  ],
  "link": [
    {
      "URL": "http://link.springer.com/content/pdf/10.1007/s00439-016-1647-9.pdf",
      "content-type": "application/pdf",
      "content-version": "vor",
      "intended-application": "text-mining"
    },
    {
      "URL": "http://link.springer.com/article/10.1007/s00439-016-1647-9/fulltext.html",
      "content-type": "text/html",
      "content-version": "vor",
      "intended-application": "text-mining"
    },
    {
      "URL": "http://link.springer.com/content/pdf/10.1007/s00439-016-1647-9",
      "content-type": "unspecified",
      "content-version": "vor",
      "intended-application": "similarity-checking"
    },
    {
      "URL": "http://link.springer.com/content/pdf/10.1007/s00439-016-1647-9.pdf",
      "content-type": "application/pdf",
      "content-version": "vor",
      "intended-application": "similarity-checking"
    }
  ],
  "member": "297",
  "page": "453-467",
  "prefix": "10.1007",
  "published": {
    "date-parts": [
      [
        2016,
        3,
        5
      ]
    ]
  },
  "published-online": {
    "date-parts": [
      [
        2016,
        3,
        5
      ]
    ]
  },
  "published-print": {
    "date-parts": [
      [
        2016,
        5
      ]
    ]
  },
  "publisher": "Springer Science and Business Media LLC",
  "reference": [
    {
      "DOI": "10.1016/j.jacc.2009.11.069",
      "author": "F Akdim",
      "doi-asserted-by": "publisher",
      "first-page": "1611",
      "journal-title": "J Am Coll Cardiol",
      "key": "1647_CR1",
      "unstructured": "Akdim F, Stroes ES, Sijbrands EJ, Tribble DL, Trip MD, Jukema JW, Flaim JD, Su J, Yu R, Baker BF, Wedel MK, Kastelein JJ (2010) Efficacy and safety of mipomersen, an antisense inhibitor of apolipoprotein B, in hypercholesterolemic subjects receiving stable statin therapy. J Am Coll Cardiol 55:1611–1618. doi:\n                  10.1016/j.jacc.2009.11.069",
      "volume": "55",
      "year": "2010"
    },
    {
      "DOI": "10.1136/bmj.316.7141.1337",
      "author": "C Baigent",
      "doi-asserted-by": "publisher",
      "first-page": "1337",
      "journal-title": "BMJ",
      "key": "1647_CR2",
      "unstructured": "Baigent C, Collins R, Appleby P, Parish S, Sleight P, Peto R (1998) ISIS-2: 10 year survival among patients with suspected acute myocardial infarction in randomised comparison of intravenous streptokinase, oral aspirin, both, or neither. The ISIS-2 (Second International Study of Infarct Survival) Collaborative Group. BMJ 316:1337–1343",
      "volume": "316",
      "year": "1998"
    },
    {
      "DOI": "10.1016/j.ahj.2008.09.022",
      "author": "D Bloomfield",
      "doi-asserted-by": "publisher",
      "first-page": "e2",
      "issue": "352–360",
      "journal-title": "Am Heart J",
      "key": "1647_CR3",
      "unstructured": "Bloomfield D, Carlson GL, Sapre A, Tribble D, McKenney JM, Littlejohn TW 3rd, Sisk CM, Mitchel Y, Pasternak RC (2009) Efficacy and safety of the cholesteryl ester transfer protein inhibitor anacetrapib as monotherapy and coadministered with atorvastatin in dyslipidemic patients. Am Heart J 157(352–360):e2. doi:\n                  10.1016/j.ahj.2008.09.022",
      "volume": "157",
      "year": "2009"
    },
    {
      "DOI": "10.1093/ije/dyv080",
      "author": "J Bowden",
      "doi-asserted-by": "publisher",
      "first-page": "512",
      "journal-title": "Int J Epidemiol",
      "key": "1647_CR4",
      "unstructured": "Bowden J, Davey Smith G, Burgess S (2015) Mendelian randomization with invalid instruments: effect estimation and bias detection through Egger regression. Int J Epidemiol 44:512–525. doi:\n                  10.1093/ije/dyv080",
      "volume": "44",
      "year": "2015"
    },
    {
      "DOI": "10.1093/aje/kwu283",
      "author": "S Burgess",
      "doi-asserted-by": "publisher",
      "first-page": "251",
      "issue": "181",
      "journal-title": "Am J Epidemiol",
      "key": "1647_CR5",
      "unstructured": "Burgess S, Thompson SG (2015) Multivariable Mendelian randomization: the use of pleiotropic genetic variants to estimate causal effects. Am J Epidemiol 181:251–260. doi:\n                  10.1093/aje/kwu283",
      "volume": "15",
      "year": "2015"
    },
    {
      "DOI": "10.1056/NEJMoa1410489",
      "author": "Christopher P. Cannon",
      "doi-asserted-by": "publisher",
      "first-page": "2387",
      "issue": "25",
      "journal-title": "New England Journal of Medicine",
      "key": "1647_CR6",
      "unstructured": "Cannon CP, Blazing MA, Giugliano RP, McCagg A, White JA, Theroux P, Darius H, Lewis BS, Ophuis TO, Jukema JW, De Ferrari GM, Ruzyllo W, De Lucca P, Im K, Bohula EA, Reist C, Wiviott SD, Tershakovec AM, Musliner TA, Braunwald E, Califf RM, Investigators I-I (2015) Ezetimibe added to statin therapy after acute coronary syndromes. N Engl J Med. doi:\n                  10.1056/NEJMoa1410489",
      "volume": "372",
      "year": "2015"
    },
    {
      "DOI": "10.1097/FPC.0b013e32833fe789",
      "author": "L Chen",
      "doi-asserted-by": "publisher",
      "first-page": "687",
      "journal-title": "Pharmacogenet Genomics",
      "key": "1647_CR7",
      "unstructured": "Chen L, Pawlikowski B, Schlessinger A, More SS, Stryke D, Johns SJ, Portman MA, Chen E, Ferrin TE, Sali A, Giacomini KM (2010) Role of organic cation transporter 3 (SLC22A3) and its missense variants in the pharmacologic action of metformin. Pharmacogenet Genomics 20:687–699. doi:\n                  10.1097/FPC.0b013e32833fe789",
      "volume": "20",
      "year": "2010"
    },
    {
      "DOI": "10.1016/S0140-6736(10)61350-5",
      "author": "C Cholesterol Treatment Trialists",
      "doi-asserted-by": "publisher",
      "first-page": "1670",
      "journal-title": "Lancet",
      "key": "1647_CR8",
      "unstructured": "Cholesterol Treatment Trialists C, Baigent C, Blackwell L, Emberson J, Holland LE, Reith C, Bhala N, Peto R, Barnes EH, Keech A, Simes J, Collins R (2010) Efficacy and safety of more intensive lowering of LDL cholesterol: a meta-analysis of data from 170,000 participants in 26 randomised trials. Lancet 376:1670–1681. doi:\n                  10.1016/S0140-6736(10)61350-5",
      "volume": "376",
      "year": "2010"
    },
    {
      "DOI": "10.1016/S0140-6736(12)60367-5",
      "author": "C Cholesterol Treatment Trialists",
      "doi-asserted-by": "publisher",
      "first-page": "581",
      "journal-title": "Lancet",
      "key": "1647_CR9",
      "unstructured": "Cholesterol Treatment Trialists C, Mihaylova B, Emberson J, Blackwell L, Keech A, Simes J, Barnes EH, Voysey M, Gray A, Collins R, Baigent C (2012) The effects of lowering LDL cholesterol with statin therapy in people at low risk of vascular disease: meta-analysis of individual data from 27 randomised trials. Lancet 380:581–590. doi:\n                  10.1016/S0140-6736(12)60367-5",
      "volume": "380",
      "year": "2012"
    },
    {
      "DOI": "10.1038/ng.2480",
      "author": "Panos Deloukas",
      "doi-asserted-by": "publisher",
      "first-page": "25",
      "issue": "1",
      "journal-title": "Nature Genetics",
      "key": "1647_CR10",
      "unstructured": "Consortium CAD, Deloukas P, Kanoni S, Willenborg C, Farrall M, Assimes TL, Thompson JR, Ingelsson E, Saleheen D, Erdmann J, Goldstein BA, Stirrups K, Konig IR, Cazier JB, Johansson A, Hall AS, Lee JY, Willer CJ, Chambers JC, Esko T, Folkersen L, Goel A, Grundberg E, Havulinna AS, Ho WK, Hopewell JC, Eriksson N, Kleber ME, Kristiansson K, Lundmark P, Lyytikainen LP, Rafelt S, Shungin D, Strawbridge RJ, Thorleifsson G, Tikkanen E, Van Zuydam N, Voight BF, Waite LL, Zhang W, Ziegler A, Absher D, Altshuler D, Balmforth AJ, Barroso I, Braund PS, Burgdorf C, Claudi-Boehm S, Cox D, Dimitriou M, Do R, Consortium D, Consortium C, Doney AS, El Mokhtari N, Eriksson P, Fischer K, Fontanillas P, Franco-Cereceda A, Gigante B, Groop L, Gustafsson S, Hager J, Hallmans G, Han BG, Hunt SE, Kang HM, Illig T, Kessler T, Knowles JW, Kolovou G, Kuusisto J, Langenberg C, Langford C, Leander K, Lokki ML, Lundmark A, McCarthy MI, Meisinger C, Melander O, Mihailov E, Maouche S, Morris AD, Muller-Nurasyid M, Mu TC, Nikus K, Peden JF, Rayner NW, Rasheed A, Rosinger S, Rubin D, Rumpf MP, Schafer A, Sivananthan M, Song C, Stewart AF, Tan ST, Thorgeirsson G, van der Schoot CE, Wagner PJ et al (2013) Large-scale association analysis identifies new risk loci for coronary artery disease. Nat Genet 45:25–33. doi:\n                  10.1038/ng.2480",
      "volume": "45",
      "year": "2012"
    },
    {
      "DOI": "10.1038/nrg2579",
      "author": "HJ Cordell",
      "doi-asserted-by": "publisher",
      "first-page": "392",
      "journal-title": "Nat Rev Genet",
      "key": "1647_CR11",
      "unstructured": "Cordell HJ (2009) Detecting gene-gene interactions that underlie human diseases. Nat Rev Genet 10:392–404. doi:\n                  10.1038/nrg2579",
      "volume": "10",
      "year": "2009"
    },
    {
      "DOI": "10.1161/atv81.9.6.2511826",
      "author": "DJ Crutchley",
      "doi-asserted-by": "publisher",
      "first-page": "934",
      "journal-title": "Arteriosclerosis",
      "key": "1647_CR12",
      "unstructured": "Crutchley DJ, McPhee GV, Terris MF, Canossa-Terris MA (1989) Levels of three hemostatic factors in relation to serum lipids. Monocyte procoagulant activity, tissue plasminogen activator, and type-1 plasminogen activator inhibitor. Arteriosclerosis 9:934–939",
      "volume": "9",
      "year": "1989"
    },
    {
      "DOI": "10.1186/s13040-015-0074-0",
      "author": "R De",
      "doi-asserted-by": "publisher",
      "first-page": "41",
      "journal-title": "BioData Min",
      "key": "1647_CR13",
      "unstructured": "De R, Verma SS, Drenos F, Holzinger ER, Holmes MV, Hall MA, Crosslin DR, Carrell DS, Hakonarson H, Jarvik G, Larson E, Pacheco JA, Rasmussen-Torvik LJ, Moore CB, Asselbergs FW, Moore JH, Ritchie MD, Keating BJ, Gilbert-Diamond D (2015) Identifying gene-gene interactions that are highly associated with Body Mass Index using Quantitative Multifactor Dimensionality Reduction (QMDR). BioData Min 8:41. doi:\n                  10.1186/s13040-015-0074-0",
      "volume": "8",
      "year": "2015"
    },
    {
      "DOI": "10.1111/j.1747-4949.2011.00739.x",
      "author": "HC Diener",
      "doi-asserted-by": "publisher",
      "first-page": "139",
      "journal-title": "Int J Stroke",
      "key": "1647_CR14",
      "unstructured": "Diener HC, Eikelboom J, Granger CB, Hacke W (2012) The king is dead (warfarin): direct thrombin and factor Xa inhibitors: the next Diadochian War? Int J Stroke 7:139–141. doi:\n                  10.1111/j.1747-4949.2011.00739.x",
      "volume": "7",
      "year": "2012"
    },
    {
      "DOI": "10.1016/j.ajhg.2012.02.020",
      "author": "D Ellinghaus",
      "doi-asserted-by": "publisher",
      "first-page": "636",
      "journal-title": "Am J Hum Genet",
      "key": "1647_CR15",
      "unstructured": "Ellinghaus D, Ellinghaus E, Nair RP, Stuart PE, Esko T, Metspalu A, Debrus S, Raelson JV, Tejasvi T, Belouchi M, West SL, Barker JN, Koks S, Kingo K, Balschun T, Palmieri O, Annese V, Gieger C, Wichmann HE, Kabesch M, Trembath RC, Mathew CG, Abecasis GR, Weidinger S, Nikolaus S, Schreiber S, Elder JT, Weichenthal M, Nothnagel M, Franke A (2012) Combined analysis of genome-wide association studies for Crohn disease and psoriasis identifies seven shared susceptibility loci. Am J Hum Genet 90:636–647. doi:\n                  10.1016/j.ajhg.2012.02.020",
      "volume": "90",
      "year": "2012"
    },
    {
      "DOI": "10.1016/j.jacc.2015.02.020",
      "author": "BA Ference",
      "doi-asserted-by": "publisher",
      "first-page": "1552",
      "journal-title": "J Am Coll Cardiol",
      "key": "1647_CR16",
      "unstructured": "Ference BA, Majeed F, Penumetcha R, Flack JM, Brook RD (2015) Effect of naturally random allocation to lower low-density lipoprotein cholesterol on the risk of coronary heart disease mediated by polymorphisms in NPC1L1, HMGCR, or both: a 2 × 2 Factorial Mendelian Randomization Study. J Am Coll Cardiol 65:1552–1561. doi:\n                  10.1016/j.jacc.2015.02.020",
      "volume": "65",
      "year": "2015"
    },
    {
      "DOI": "10.1016/j.jacc.2015.03.016",
      "author": "CB Fordyce",
      "doi-asserted-by": "publisher",
      "first-page": "1567",
      "journal-title": "J Am Coll Cardiol",
      "key": "1647_CR17",
      "unstructured": "Fordyce CB, Roe MT, Ahmad T, Libby P, Borer JS, Hiatt WR, Bristow MR, Packer M, Wasserman SM, Braunstein N, Pitt B, DeMets DL, Cooper-Arnold K, Armstrong PW, Berkowitz SD, Scott R, Prats J, Galis ZS, Stockbridge N, Peterson ED, Califf RM (2015) Cardiovascular drug development: is it dead or just hibernating? J Am Coll Cardiol 65:1567–1582. doi:\n                  10.1016/j.jacc.2015.03.016",
      "volume": "65",
      "year": "2015"
    },
    {
      "DOI": "10.1073/pnas.0500269102",
      "author": "M Garcia-Calvo",
      "doi-asserted-by": "publisher",
      "first-page": "8132",
      "journal-title": "Proc Natl Acad Sci USA",
      "key": "1647_CR18",
      "unstructured": "Garcia-Calvo M, Lisnock J, Bull HG, Hawes BE, Burnett DA, Braun MP, Crona JH, Davis HR Jr, Dean DC, Detmers PA, Graziano MP, Hughes M, Macintyre DE, Ogawa A, O’Neill KA, Iyer SP, Shevell DE, Smith MM, Tang YS, Makarewicz AM, Ujjainwalla F, Altmann SW, Chapman KT, Thornberry NA (2005) The target of ezetimibe is Niemann-Pick C1-Like 1 (NPC1L1). Proc Natl Acad Sci USA 102:8132–8137. doi:\n                  10.1073/pnas.0500269102",
      "volume": "102",
      "year": "2005"
    },
    {
      "DOI": "10.1093/nar/gkr777",
      "author": "A Gaulton",
      "doi-asserted-by": "publisher",
      "first-page": "D1100",
      "journal-title": "Nucleic Acids Res",
      "key": "1647_CR19",
      "unstructured": "Gaulton A, Bellis LJ, Bento AP, Chambers J, Davies M, Hersey A, Light Y, McGlinchey S, Michalovich D, Al-Lazikani B, Overington JP (2012) ChEMBL: a large-scale bioactivity database for drug discovery. Nucleic Acids Res 40:D1100–D1107. doi:\n                  10.1093/nar/gkr777",
      "volume": "40",
      "year": "2012"
    },
    {
      "DOI": "10.1038/ng.2797",
      "author": "Cristen J Willer",
      "doi-asserted-by": "publisher",
      "first-page": "1274",
      "issue": "11",
      "journal-title": "Nature Genetics",
      "key": "1647_CR20",
      "unstructured": "Global Lipids Genetics C, Willer CJ, Schmidt EM, Sengupta S, Peloso GM, Gustafsson S, Kanoni S, Ganna A, Chen J, Buchkovich ML, Mora S, Beckmann JS, Bragg-Gresham JL, Chang HY, Demirkan A, Den Hertog HM, Do R, Donnelly LA, Ehret GB, Esko T, Feitosa MF, Ferreira T, Fischer K, Fontanillas P, Fraser RM, Freitag DF, Gurdasani D, Heikkila K, Hypponen E, Isaacs A, Jackson AU, Johansson A, Johnson T, Kaakinen M, Kettunen J, Kleber ME, Li X, Luan J, Lyytikainen LP, Magnusson PK, Mangino M, Mihailov E, Montasser ME, Muller-Nurasyid M, Nolte IM, O’Connell JR, Palmer CD, Perola M, Petersen AK, Sanna S, Saxena R, Service SK, Shah S, Shungin D, Sidore C, Song C, Strawbridge RJ, Surakka I, Tanaka T, Teslovich TM, Thorleifsson G, Van den Herik EG, Voight BF, Volcik KA, Waite LL, Wong A, Wu Y, Zhang W, Absher D, Asiki G, Barroso I, Been LF, Bolton JL, Bonnycastle LL, Brambilla P, Burnett MS, Cesana G, Dimitriou M, Doney AS, Doring A, Elliott P, Epstein SE, Eyjolfsson GI, Gigante B, Goodarzi MO, Grallert H, Gravito ML, Groves CJ, Hallmans G, Hartikainen AL, Hayward C, Hernandez D, Hicks AA, Holm H, Hung YJ, Illig T, Jones MR, Kaleebu P, Kastelein JJ, Khaw KT et al (2013) Discovery and refinement of loci associated with lipid levels. Nat Genet 45:1274–1283. doi:\n                  10.1038/ng.2797",
      "volume": "45",
      "year": "2013"
    },
    {
      "DOI": "10.1038/clpt.2011.271",
      "author": "DE Gutstein",
      "doi-asserted-by": "publisher",
      "first-page": "109",
      "journal-title": "Clin Pharmacol Ther",
      "key": "1647_CR21",
      "unstructured": "Gutstein DE, Krishna R, Johns D, Surks HK, Dansky HM, Shah S, Mitchel YB, Arena J, Wagner JA (2012) Anacetrapib, a novel CETP inhibitor: pursuing a new approach to cardiovascular risk reduction. Clin Pharmacol Ther 91:109–122. doi:\n                  10.1038/clpt.2011.271",
      "volume": "91",
      "year": "2012"
    },
    {
      "DOI": "10.1097/MOL.0b013e328353ef1d",
      "author": "B Hewing",
      "doi-asserted-by": "publisher",
      "first-page": "372",
      "journal-title": "Curr Opin Lipidol",
      "key": "1647_CR22",
      "unstructured": "Hewing B, Fisher EA (2012) Rationale for cholesteryl ester transfer protein inhibition. Curr Opin Lipidol 23:372–376. doi:\n                  10.1097/MOL.0b013e328353ef1d",
      "volume": "23",
      "year": "2012"
    },
    {
      "DOI": "10.1016/j.jacc.2013.06.044",
      "author": "MV Holmes",
      "doi-asserted-by": "publisher",
      "first-page": "1966",
      "journal-title": "J Am Coll Cardiol",
      "key": "1647_CR23",
      "unstructured": "Holmes MV, Simon T, Exeter HJ, Folkersen L, Asselbergs FW, Guardiola M, Cooper JA, Palmen J, Hubacek JA, Carruthers KF, Horne BD, Brunisholz KD, Mega JL, van Iperen EP, Li M, Leusink M, Trompet S, Verschuren JJ, Hovingh GK, Dehghan A, Nelson CP, Kotti S, Danchin N, Scholz M, Haase CL, Rothenbacher D, Swerdlow DI, Kuchenbaecker KB, Staines-Urias E, Goel A, van’t Hooft F, Gertow K, de Faire U, Panayiotou AG, Tremoli E, Baldassarre D, Veglia F, Holdt LM, Beutner F, Gansevoort RT, Navis GJ, Mateo Leach I, Breitling LP, Brenner H, Thiery J, Dallmeier D, Franco-Cereceda A, Boer JM, Stephens JW, Hofker MH, Tedgui A, Hofman A, Uitterlinden AG, Adamkova V, Pitha J, Onland-Moret NC, Cramer MJ, Nathoe HM, Spiering W, Klungel OH, Kumari M, Whincup PH, Morrow DA, Braund PS, Hall AS, Olsson AG, Doevendans PA, Trip MD, Tobin MD, Hamsten A, Watkins H, Koenig W, Nicolaides AN, Teupser D, Day IN, Carlquist JF, Gaunt TR, Ford I, Sattar N, Tsimikas S, Schwartz GG, Lawlor DA, Morris RW, Sandhu MS, Poledne R, Maitland-van der Zee AH, Khaw KT, Keating BJ, van der Harst P, Price JF, Mehta SR, Yusuf S, Witteman JC, Franco OH, Jukema JW, de Knijff P, Tybjaerg-Hansen A, Rader DJ, Farrall M, Samani NJ et al (2013) Secretory phospholipase A(2)-IIA and cardiovascular disease: a mendelian randomization study. J Am Coll Cardiol 62:1966–1976. doi:\n                  10.1016/j.jacc.2013.06.044",
      "volume": "62",
      "year": "2013"
    },
    {
      "DOI": "10.1136/bmj.g4164",
      "author": "MV Holmes",
      "doi-asserted-by": "publisher",
      "first-page": "g4164",
      "journal-title": "BMJ",
      "key": "1647_CR25",
      "unstructured": "Holmes MV, Dale CE, Zuccolo L, Silverwood RJ, Guo Y, Ye Z, Prieto-Merino D, Dehghan A, Trompet S, Wong A, Cavadino A, Drogan D, Padmanabhan S, Li S, Yesupriya A, Leusink M, Sundstrom J, Hubacek JA, Pikhart H, Swerdlow DI, Panayiotou AG, Borinskaya SA, Finan C, Shah S, Kuchenbaecker KB, Shah T, Engmann J, Folkersen L, Eriksson P, Ricceri F, Melander O, Sacerdote C, Gamble DM, Rayaprolu S, Ross OA, McLachlan S, Vikhireva O, Sluijs I, Scott RA, Adamkova V, Flicker L, Bockxmeer FM, Power C, Marques-Vidal P, Meade T, Marmot MG, Ferro JM, Paulos-Pinheiro S, Humphries SE, Talmud PJ, Mateo Leach I, Verweij N, Linneberg A, Skaaby T, Doevendans PA, Cramer MJ, van der Harst P, Klungel OH, Dowling NF, Dominiczak AF, Kumari M, Nicolaides AN, Weikert C, Boeing H, Ebrahim S, Gaunt TR, Price JF, Lannfelt L, Peasey A, Kubinova R, Pajak A, Malyutina S, Voevoda MI, Tamosiunas A, Maitland-van der Zee AH, Norman PE, Hankey GJ, Bergmann MM, Hofman A, Franco OH, Cooper J, Palmen J, Spiering W, de Jong PA, Kuh D, Hardy R, Uitterlinden AG, Ikram MA, Ford I, Hypponen E, Almeida OP, Wareham NJ, Khaw KT, Hamsten A, Husemoen LL, Tjonneland A, Tolstrup JS, Rimm E, Beulens JW, Verschuren WM et al (2014) Association between alcohol and cardiovascular disease: Mendelian randomisation analysis based on individual participant data. BMJ 349:g4164. doi:\n                  10.1136/bmj.g4164",
      "volume": "349",
      "year": "2014"
    },
    {
      "DOI": "10.1093/eurheartj/eht571",
      "author": "MV Holmes",
      "doi-asserted-by": "publisher",
      "first-page": "539",
      "journal-title": "Eur Heart J",
      "key": "1647_CR24",
      "unstructured": "Holmes MV, Asselbergs FW, Palmer TM, Drenos F, Lanktree MB, Nelson CP, Dale CE, Padmanabhan S, Finan C, Swerdlow DI, Tragante V, van Iperen EP, Sivapalaratnam S, Shah S, Elbers CC, Shah T, Engmann J, Giambartolomei C, White J, Zabaneh D, Sofat R, McLachlan S, on behalf of the Uc, Doevendans PA, Balmforth AJ, Hall AS, North KE, Almoguera B, Hoogeveen RC, Cushman M, Fornage M, Patel SR, Redline S, Siscovick DS, Tsai MY, Karczewski KJ, Hofker MH, Verschuren WM, Bots ML, van der Schouw YT, Melander O, Dominiczak AF, Morris R, Ben-Shlomo Y, Price J, Kumari M, Baumert J, Peters A, Thorand B, Koenig W, Gaunt TR, Humphries SE, Clarke R, Watkins H, Farrall M, Wilson JG, Rich SS, de Bakker PI, Lange LA, Davey Smith G, Reiner AP, Talmud PJ, Kivimaki M, Lawlor DA, Dudbridge F, Samani NJ, Keating BJ, Hingorani AD, Casas JP (2015) Mendelian randomization of blood lipids for coronary heart disease. Eur Heart J 36:539–550. doi:\n                  10.1093/eurheartj/eht571",
      "volume": "36",
      "year": "2015"
    },
    {
      "DOI": "10.1056/NEJMe1507041",
      "author": "John A. Jarcho",
      "doi-asserted-by": "publisher",
      "first-page": "2448",
      "issue": "25",
      "journal-title": "New England Journal of Medicine",
      "key": "1647_CR26",
      "unstructured": "Jarcho JA, Keaney JF Jr (2015) Proof that lower is better—LDL cholesterol and IMPROVE-IT. N Engl J Med. doi:\n                  10.1056/NEJMe1507041",
      "volume": "372",
      "year": "2015"
    },
    {
      "DOI": "10.1056/NEJMoa0800742",
      "author": "JJ Kastelein",
      "doi-asserted-by": "publisher",
      "first-page": "1431",
      "journal-title": "N Engl J Med",
      "key": "1647_CR27",
      "unstructured": "Kastelein JJ, Akdim F, Stroes ES, Zwinderman AH, Bots ML, Stalenhoef AF, Visseren FL, Sijbrands EJ, Trip MD, Stein EA, Gaudet D, Duivenvoorden R, Veltri EP, Marais AD, de Groot E, Investigators E (2008) Simvastatin with or without ezetimibe in familial hypercholesterolemia. N Engl J Med 358:1431–1443. doi:\n                  10.1056/NEJMoa0800742",
      "volume": "358",
      "year": "2008"
    },
    {
      "DOI": "10.1016/j.jacc.2015.02.049",
      "author": "S Kathiresan",
      "doi-asserted-by": "publisher",
      "first-page": "1562",
      "journal-title": "J Am Coll Cardiol",
      "key": "1647_CR28",
      "unstructured": "Kathiresan S (2015) Developing medicines that mimic the natural successes of the human genome: lessons from NPC1L1, HMGCR, PCSK9, APOC3, and CETP. J Am Coll Cardiol 65:1562–1566. doi:\n                  10.1016/j.jacc.2015.02.049",
      "volume": "65",
      "year": "2015"
    },
    {
      "DOI": "10.1371/journal.pone.0094585",
      "author": "N Kaur",
      "doi-asserted-by": "publisher",
      "first-page": "e94585",
      "journal-title": "PLoS One",
      "key": "1647_CR29",
      "unstructured": "Kaur N, Pandey A, Negi H, Shafiq N, Reddy S, Kaur H, Chadha N, Malhotra S (2014) Effect of HDL-raising drugs on cardiovascular outcomes: a systematic review and meta-regression. PLoS One 9:e94585. doi:\n                  10.1371/journal.pone.0094585",
      "volume": "9",
      "year": "2014"
    },
    {
      "DOI": "10.1136/bmj.g4379",
      "author": "D Keene",
      "doi-asserted-by": "publisher",
      "first-page": "g4379",
      "journal-title": "BMJ",
      "key": "1647_CR30",
      "unstructured": "Keene D, Price C, Shun-Shin MJ, Francis DP (2014) Effect on cardiovascular risk of high density lipoprotein targeted drug treatments niacin, fibrates, and CETP inhibitors: meta-analysis of randomised controlled trials including 117,411 patients. BMJ 349:g4379. doi:\n                  10.1136/bmj.g4379",
      "volume": "349",
      "year": "2014"
    },
    {
      "DOI": "10.1177/14746514020020011801",
      "author": "B Keidan",
      "doi-asserted-by": "publisher",
      "first-page": "40",
      "journal-title": "Br J Diabetes Vasc Dis",
      "key": "1647_CR31",
      "unstructured": "Keidan B, Hsia J, Katz R (2002) Plasma lipids and antidiabetic agents: a brief overview. Br J Diabetes Vasc Dis 2:40–43",
      "volume": "2",
      "year": "2002"
    },
    {
      "DOI": "10.1161/CIRCULATIONAHA.113.007012",
      "author": "MJ Koren",
      "doi-asserted-by": "publisher",
      "first-page": "234",
      "journal-title": "Circulation",
      "key": "1647_CR32",
      "unstructured": "Koren MJ, Giugliano RP, Raal FJ, Sullivan D, Bolognese M, Langslet G, Civeira F, Somaratne R, Nelson P, Liu T, Scott R, Wasserman SM, Sabatine MS, Investigators O (2014) Efficacy and safety of longer-term administration of evolocumab (AMG 145) in patients with hypercholesterolemia: 52-week results from the Open-Label Study of Long-Term Evaluation Against LDL-C (OSLER) randomized trial. Circulation 129:234–243. doi:\n                  10.1161/CIRCULATIONAHA.113.007012",
      "volume": "129",
      "year": "2014"
    },
    {
      "DOI": "10.1111/j.1463-1326.2010.01349.x",
      "author": "C Lamanna",
      "doi-asserted-by": "publisher",
      "first-page": "221",
      "journal-title": "Diabetes Obes Metab",
      "key": "1647_CR33",
      "unstructured": "Lamanna C, Monami M, Marchionni N, Mannucci E (2011) Effect of metformin on cardiovascular events and mortality: a meta-analysis of randomized clinical trials. Diabetes Obes Metab 13:221–228. doi:\n                  10.1111/j.1463-1326.2010.01349.x",
      "volume": "13",
      "year": "2011"
    },
    {
      "DOI": "10.1093/nar/gkt1068",
      "author": "V Law",
      "doi-asserted-by": "publisher",
      "first-page": "D1091",
      "journal-title": "Nucleic Acids Res",
      "key": "1647_CR34",
      "unstructured": "Law V, Knox C, Djoumbou Y, Jewison T, Guo AC, Liu Y, Maciejewski A, Arndt D, Wilson M, Neveu V, Tang A, Gabriel G, Ly C, Adamjee S, Dame ZT, Han B, Zhou Y, Wishart DS (2014) DrugBank 4.0: shedding new light on drug metabolism. Nucleic Acids Res 42:D1091–D1097. doi:\n                  10.1093/nar/gkt1068",
      "volume": "42",
      "year": "2014"
    },
    {
      "DOI": "10.1002/sim.3034",
      "author": "DA Lawlor",
      "doi-asserted-by": "publisher",
      "first-page": "1133",
      "journal-title": "Stat Med",
      "key": "1647_CR35",
      "unstructured": "Lawlor DA, Harbord RM, Sterne JA, Timpson N, Davey Smith G (2008) Mendelian randomization: using genes as instruments for making causal inferences in epidemiology. Stat Med 27:1133–1163. doi:\n                  10.1002/sim.3034",
      "volume": "27",
      "year": "2008"
    },
    {
      "key": "1647_CR36",
      "unstructured": "Lilly (2015) Lilly to discontinue development of evacetrapib for high-risk atherosclerotic cardiovascular disease. \n                  https://investor.lilly.com/releasedetail.cfm?ReleaseID=936130\n                  \n                . Accessed 5 Nov 2015"
    },
    {
      "DOI": "10.1002/gepi.20435",
      "author": "DY Lin",
      "doi-asserted-by": "publisher",
      "first-page": "60",
      "journal-title": "Genet Epidemiol",
      "key": "1647_CR37",
      "unstructured": "Lin DY, Zeng D (2010) Meta-analysis of genome-wide association studies: no efficiency gain in using individual participant data. Genet Epidemiol 34:60–66. doi:\n                  10.1002/gepi.20435",
      "volume": "34",
      "year": "2010"
    },
    {
      "DOI": "10.1016/j.ehj.2003.11.004",
      "author": "GD Lowe",
      "doi-asserted-by": "publisher",
      "first-page": "252",
      "journal-title": "Eur Heart J",
      "key": "1647_CR38",
      "unstructured": "Lowe GD, Danesh J, Lewington S, Walker M, Lennon L, Thomson A, Rumley A, Whincup PH (2004) Tissue plasminogen activator antigen and coronary heart disease. Prospective study and meta-analysis. Eur Heart J 25:252–259. doi:\n                  10.1016/j.ehj.2003.11.004",
      "volume": "25",
      "year": "2004"
    },
    {
      "DOI": "10.7326/0003-4819-88-1-53",
      "author": "LF Major",
      "doi-asserted-by": "publisher",
      "first-page": "53",
      "journal-title": "Ann Intern Med",
      "key": "1647_CR39",
      "unstructured": "Major LF, Goyer PF (1978) Effects of disulfiram and pyridoxine on serum cholesterol. Ann Intern Med 88:53–56",
      "volume": "88",
      "year": "1978"
    },
    {
      "DOI": "10.1016/j.gdata.2014.04.004",
      "author": "MJ McGeachie",
      "doi-asserted-by": "publisher",
      "first-page": "202",
      "journal-title": "Genomics Data",
      "key": "1647_CR40",
      "unstructured": "McGeachie MJ, Clemmer GL, Lasky-Su J, Dahlin A, Raby BA, Weiss ST (2014) Joint GWAS Analysis: comparing similar GWAS at different genomic resolutions identifies novel pathway associations with six complex diseases. Genomics Data 2:202–211. doi:\n                  10.1016/j.gdata.2014.04.004",
      "volume": "2",
      "year": "2014"
    },
    {
      "DOI": "10.1161/ATVBAHA.114.305012",
      "author": "R McPherson",
      "doi-asserted-by": "publisher",
      "first-page": "e13",
      "journal-title": "Arterioscler Thromb Vasc Biol",
      "key": "1647_CR41",
      "unstructured": "McPherson R, Hegele RA (2015) Ezetimibe: rescued by randomization (clinical and mendelian). Arterioscler Thromb Vasc Biol 35:e13–e15. doi:\n                  10.1161/ATVBAHA.114.305012",
      "volume": "35",
      "year": "2015"
    },
    {
      "DOI": "10.12688/f1000research.4396.1",
      "author": "NE Miller",
      "doi-asserted-by": "publisher",
      "first-page": "124",
      "journal-title": "F1000Res",
      "key": "1647_CR42",
      "unstructured": "Miller NE (2014) CETP inhibitors and cardiovascular disease: time to think again. F1000Res 3:124. doi:\n                  10.12688/f1000research.4396.1",
      "volume": "3",
      "year": "2014"
    },
    {
      "DOI": "10.1007/s40262-013-0071-8",
      "author": "AH Mohammadpour",
      "doi-asserted-by": "publisher",
      "first-page": "615",
      "journal-title": "Clin Pharmacokinet",
      "key": "1647_CR43",
      "unstructured": "Mohammadpour AH, Akhlaghi F (2013) Future of cholesteryl ester transfer protein (CETP) inhibitors: a pharmacological perspective. Clin Pharmacokinet 52:615–626. doi:\n                  10.1007/s40262-013-0071-8",
      "volume": "52",
      "year": "2013"
    },
    {
      "DOI": "10.1056/NEJMoa1405386",
      "author": "NO Stitziel",
      "doi-asserted-by": "publisher",
      "first-page": "2072",
      "journal-title": "N Engl J Med",
      "key": "1647_CR44",
      "unstructured": "Myocardial Infarction Genetics Consortium I, Stitziel NO, Won HH, Morrison AC, Peloso GM, Do R, Lange LA, Fontanillas P, Gupta N, Duga S, Goel A, Farrall M, Saleheen D, Ferrario P, Konig I, Asselta R, Merlini PA, Marziliano N, Notarangelo MF, Schick U, Auer P, Assimes TL, Reilly M, Wilensky R, Rader DJ, Hovingh GK, Meitinger T, Kessler T, Kastrati A, Laugwitz KL, Siscovick D, Rotter JI, Hazen SL, Tracy R, Cresci S, Spertus J, Jackson R, Schwartz SM, Natarajan P, Crosby J, Muzny D, Ballantyne C, Rich SS, O’Donnell CJ, Abecasis G, Sunyaev S, Nickerson DA, Buring JE, Ridker PM, Chasman DI, Austin E, Ye Z, Kullo IJ, Weeke PE, Shaffer CM, Bastarache LA, Denny JC, Roden DM, Palmer C, Deloukas P, Lin DY, Tang ZZ, Erdmann J, Schunkert H, Danesh J, Marrugat J, Elosua R, Ardissino D, McPherson R, Watkins H, Reiner AP, Wilson JG, Altshuler D, Gibbs RA, Lander ES, Boerwinkle E, Gabriel S, Kathiresan S (2014) Inactivating mutations in NPC1L1 and protection from coronary heart disease. N Engl J Med 371:2072–2082. doi:\n                  10.1056/NEJMoa1405386",
      "volume": "371",
      "year": "2014"
    },
    {
      "DOI": "10.1038/ng.3314",
      "author": "MR Nelson",
      "doi-asserted-by": "publisher",
      "first-page": "856",
      "journal-title": "Nat Genet",
      "key": "1647_CR45",
      "unstructured": "Nelson MR, Tipney H, Painter JL, Shen J, Nicoletti P, Shen Y, Floratos A, Sham PC, Li MJ, Wang J, Cardon LR, Whittaker JC, Sanseau P (2015) The support of human genetic evidence for approved drug indications. Nat Genet 47:856–860. doi:\n                  10.1038/ng.3314",
      "volume": "47",
      "year": "2015"
    },
    {
      "DOI": "10.1093/nar/gkt1143",
      "author": "AJ Pawson",
      "doi-asserted-by": "publisher",
      "first-page": "D1098",
      "journal-title": "Nucleic Acids Res",
      "key": "1647_CR46",
      "unstructured": "Pawson AJ, Sharman JL, Benson HE, Faccenda E, Alexander SP, Buneman OP, Davenport AP, McGrath JC, Peters JA, Southan C, Spedding M, Yu W, Harmar AJ, Nc I (2014) The IUPHAR/BPS guide to PHARMACOLOGY: an expert-driven knowledgebase of drug targets and their ligands. Nucleic Acids Res 42:D1098–D1106. doi:\n                  10.1093/nar/gkt1143",
      "volume": "42",
      "year": "2014"
    },
    {
      "DOI": "10.3109/07853899009147912",
      "author": "PJ Pentikainen",
      "doi-asserted-by": "publisher",
      "first-page": "307",
      "journal-title": "Ann Med",
      "key": "1647_CR47",
      "unstructured": "Pentikainen PJ, Voutilainen E, Aro A, Uusitupa M, Penttila I, Vapaatalo H (1990) Cholesterol lowering effect of metformin in combined hyperlipidemia: placebo controlled double blind trial. Ann Med 22:307–312",
      "volume": "22",
      "year": "1990"
    },
    {
      "DOI": "10.1001/jama.2011.860",
      "author": "D Preiss",
      "doi-asserted-by": "publisher",
      "first-page": "2556",
      "journal-title": "JAMA",
      "key": "1647_CR48",
      "unstructured": "Preiss D, Seshasai SR, Welsh P, Murphy SA, Ho JE, Waters DD, DeMicco DA, Barter P, Cannon CP, Sabatine MS, Braunwald E, Kastelein JJ, de Lemos JA, Blazing MA, Pedersen TR, Tikkanen MJ, Sattar N, Ray KK (2011) Risk of incident diabetes with intensive-dose compared with moderate-dose statin therapy: a meta-analysis. JAMA 305:2556–2564. doi:\n                  10.1001/jama.2011.860",
      "volume": "305",
      "year": "2011"
    },
    {
      "DOI": "10.1146/annurev-pharmtox-011613-135943",
      "author": "M Rask-Andersen",
      "doi-asserted-by": "publisher",
      "first-page": "9",
      "journal-title": "Annu Rev Pharmacol Toxicol",
      "key": "1647_CR49",
      "unstructured": "Rask-Andersen M, Masuram S, Schioth HB (2014) The druggable genome: evaluation of drug targets in clinical trials suggests major shifts in molecular class and indication. Annu Rev Pharmacol Toxicol 54:9–26. doi:\n                  10.1146/annurev-pharmtox-011613-135943",
      "volume": "54",
      "year": "2014"
    },
    {
      "DOI": "10.2337/diacare.21.5.701",
      "author": "AC Robinson",
      "doi-asserted-by": "publisher",
      "first-page": "701",
      "journal-title": "Diabetes Care",
      "key": "1647_CR50",
      "unstructured": "Robinson AC, Burke J, Robinson S, Johnston DG, Elkeles RS (1998) The effects of metformin on glycemic control and serum lipids in insulin-treated NIDDM patients with suboptimal metabolic control. Diabetes Care 21:701–705",
      "volume": "21",
      "year": "1998"
    },
    {
      "DOI": "10.1161/01.ATV.19.3.499",
      "author": "PA Sakkinen",
      "doi-asserted-by": "publisher",
      "first-page": "499",
      "journal-title": "Arterioscler Thromb Vasc Biol",
      "key": "1647_CR51",
      "unstructured": "Sakkinen PA, Cushman M, Psaty BM, Rodriguez B, Boineau R, Kuller LH, Tracy RP (1999) Relationship of plasmin generation to cardiovascular disease risk factors in elderly men and women. Arterioscler Thromb Vasc Biol 19:499–504",
      "volume": "19",
      "year": "1999"
    },
    {
      "DOI": "10.1016/j.amjmed.2007.09.016",
      "author": "SR Salpeter",
      "doi-asserted-by": "publisher",
      "first-page": "e2",
      "issue": "149–157",
      "journal-title": "Am J Med",
      "key": "1647_CR52",
      "unstructured": "Salpeter SR, Buckley NS, Kahn JA, Salpeter EE (2008) Meta-analysis: metformin treatment in persons at risk for diabetes mellitus. Am J Med 121(149–157):e2. doi:\n                  10.1016/j.amjmed.2007.09.016",
      "volume": "121",
      "year": "2008"
    },
    {
      "DOI": "10.1016/S0140-6736(09)61965-6",
      "author": "N Sattar",
      "doi-asserted-by": "publisher",
      "first-page": "735",
      "journal-title": "Lancet",
      "key": "1647_CR53",
      "unstructured": "Sattar N, Preiss D, Murray HM, Welsh P, Buckley BM, de Craen AJ, Seshasai SR, McMurray JJ, Freeman DJ, Jukema JW, Macfarlane PW, Packard CJ, Stott DJ, Westendorp RG, Shepherd J, Davis BR, Pressel SL, Marchioli R, Marfisi RM, Maggioni AP, Tavazzi L, Tognoni G, Kjekshus J, Pedersen TR, Cook TJ, Gotto AM, Clearfield MB, Downs JR, Nakamura H, Ohashi Y, Mizuno K, Ray KK, Ford I (2010) Statins and risk of incident diabetes: a collaborative meta-analysis of randomised statin trials. Lancet 375:735–742. doi:\n                  10.1016/S0140-6736(09)61965-6",
      "volume": "375",
      "year": "2010"
    },
    {
      "DOI": "10.1056/NEJMoa1206797",
      "author": "GG Schwartz",
      "doi-asserted-by": "publisher",
      "first-page": "2089",
      "journal-title": "N Engl J Med",
      "key": "1647_CR54",
      "unstructured": "Schwartz GG, Olsson AG, Abt M, Ballantyne CM, Barter PJ, Brumm J, Chaitman BR, Holme IM, Kallend D, Leiter LA, Leitersdorf E, McMurray JJ, Mundl H, Nicholls SJ, Shah PK, Tardif JC, Wright RS, Dal OI (2012) Effects of dalcetrapib in patients with a recent acute coronary syndrome. N Engl J Med 367:2089–2099. doi:\n                  10.1056/NEJMoa1206797",
      "volume": "367",
      "year": "2012"
    },
    {
      "DOI": "10.1161/CIRCULATIONAHA.109.865444",
      "author": "R Sofat",
      "doi-asserted-by": "publisher",
      "first-page": "52",
      "journal-title": "Circulation",
      "key": "1647_CR55",
      "unstructured": "Sofat R, Hingorani AD, Smeeth L, Humphries SE, Talmud PJ, Cooper J, Shah T, Sandhu MS, Ricketts SL, Boekholdt SM, Wareham N, Khaw KT, Kumari M, Kivimaki M, Marmot M, Asselbergs FW, van der Harst P, Dullaart RP, Navis G, van Veldhuisen DJ, Van Gilst WH, Thompson JF, McCaskie P, Palmer LJ, Arca M, Quagliarini F, Gaudio C, Cambien F, Nicaud V, Poirer O, Gudnason V, Isaacs A, Witteman JC, van Duijn CM, Pencina M, Vasan RS, D’Agostino RB Sr, Ordovas J, Li TY, Kakko S, Kauma H, Savolainen MJ, Kesaniemi YA, Sandhofer A, Paulweber B, Sorli JV, Goto A, Yokoyama S, Okumura K, Horne BD, Packard C, Freeman D, Ford I, Sattar N, McCormack V, Lawlor DA, Ebrahim S, Smith GD, Kastelein JJ, Deanfield J, Casas JP (2010) Separating the mechanism-based and off-target actions of cholesteryl ester transfer protein inhibitors with CETP gene polymorphisms. Circulation 121:52–62. doi:\n                  10.1161/CIRCULATIONAHA.109.865444",
      "volume": "121",
      "year": "2010"
    },
    {
      "DOI": "10.1056/NEJMoa1105803",
      "author": "EA Stein",
      "doi-asserted-by": "publisher",
      "first-page": "1108",
      "journal-title": "N Engl J Med",
      "key": "1647_CR56",
      "unstructured": "Stein EA, Mellis S, Yancopoulos GD, Stahl N, Logan D, Smith WB, Lisbon E, Gutierrez M, Webb C, Wu R, Du Y, Kranz T, Gasparino E, Swergold GD (2012) Effect of a monoclonal antibody to PCSK9 on LDL cholesterol. N Engl J Med 366:1108–1118. doi:\n                  10.1056/NEJMoa1105803",
      "volume": "366",
      "year": "2012"
    },
    {
      "DOI": "10.1093/eurheartj/ehu085",
      "author": "EA Stein",
      "doi-asserted-by": "publisher",
      "first-page": "2249",
      "journal-title": "Eur Heart J",
      "key": "1647_CR57",
      "unstructured": "Stein EA, Giugliano RP, Koren MJ, Raal FJ, Roth EM, Weiss R, Sullivan D, Wasserman SM, Somaratne R, Kim JB, Yang J, Liu T, Albizem M, Scott R, Sabatine MS, Investigators P (2014) Efficacy and safety of evolocumab (AMG 145), a fully human monoclonal antibody to PCSK9, in hyperlipidaemic patients on various background lipid therapies: pooled analysis of 1359 patients in four phase 2 trials. Eur Heart J 35:2249–2259. doi:\n                  10.1093/eurheartj/ehu085",
      "volume": "35",
      "year": "2014"
    },
    {
      "DOI": "10.1016/S0140-6736(14)61183-1",
      "author": "Daniel I Swerdlow",
      "doi-asserted-by": "publisher",
      "first-page": "351",
      "issue": "9965",
      "journal-title": "The Lancet",
      "key": "1647_CR58",
      "unstructured": "Swerdlow DI, Preiss D, Kuchenbaecker KB, Holmes MV, Engmann JE, Shah T, Sofat R, Stender S, Johnson PC, Scott RA, Leusink M, Verweij N, Sharp SJ, Guo Y, Giambartolomei C, Chung C, Peasey A, Amuzu A, Li K, Palmen J, Howard P, Cooper JA, Drenos F, Li YR, Lowe G, Gallacher J, Stewart MC, Tzoulaki I, Buxbaum SG, van der AD, Forouhi NG, Onland-Moret NC, van der Schouw YT, Schnabel RB, Hubacek JA, Kubinova R, Baceviciene M, Tamosiunas A, Pajak A, Topor-Madry R, Stepaniak U, Malyutina S, Baldassarre D, Sennblad B, Tremoli E, de Faire U, Veglia F, Ford I, Jukema JW, Westendorp RG, de Borst GJ, de Jong PA, Algra A, Spiering W, der Zee AH, Klungel OH, de Boer A, Doevendans PA, Eaton CB, Robinson JG, Duggan D, Diagram Consortium MCIC, Kjekshus J, Downs JR, Gotto AM, Keech AC, Marchioli R, Tognoni G, Sever PS, Poulter NR, Waters DD, Pedersen TR, Amarenco P, Nakamura H, McMurray JJ, Lewsey JD, Chasman DI, Ridker PM, Maggioni AP, Tavazzi L, Ray KK, Seshasai SR, Manson JE, Price JF, Whincup PH, Morris RW, Lawlor DA, Smith GD, Ben-Shlomo Y, Schreiner PJ, Fornage M, Siscovick DS, Cushman M, Kumari M, Wareham NJ, Verschuren WM, Redline S, Patel SR, Whittaker JC, Hamsten A et al (2015) HMG-coenzyme A reductase inhibition, type 2 diabetes, and bodyweight: evidence from genetic analysis and randomised trials. Lancet 385:351–361. doi:\n                  10.1016/S0140-6736(14)61183-1",
      "volume": "385",
      "year": "2015"
    },
    {
      "DOI": "10.1056/NEJMoa0907569",
      "author": "AJ Taylor",
      "doi-asserted-by": "publisher",
      "first-page": "2113",
      "journal-title": "N Engl J Med",
      "key": "1647_CR59",
      "unstructured": "Taylor AJ, Villines TC, Stanek EJ, Devine PJ, Griffen L, Miller M, Weissman NJ, Turco M (2009) Extended-release niacin or ezetimibe and carotid intima-media thickness. N Engl J Med 361:2113–2122. doi:\n                  10.1056/NEJMoa0907569",
      "volume": "361",
      "year": "2009"
    },
    {
      "DOI": "10.1016/j.annepidem.2006.12.005",
      "author": "DC Thomas",
      "doi-asserted-by": "publisher",
      "first-page": "511",
      "journal-title": "Ann Epidemiol",
      "key": "1647_CR60",
      "unstructured": "Thomas DC, Lawlor DA, Thompson JR et al (2007) Re: estimation of bias in nongenetic observational studies using “Mendelian triangulation” by Bautista et al. Ann Epidemiol 17:511–513. doi:\n                  10.1016/j.annepidem.2006.12.005",
      "volume": "17",
      "year": "2007"
    },
    {
      "DOI": "10.2217/pgs.10.15",
      "author": "CF Thorn",
      "doi-asserted-by": "publisher",
      "first-page": "501",
      "journal-title": "Pharmacogenomics",
      "key": "1647_CR61",
      "unstructured": "Thorn CF, Klein TE, Altman RB (2010) Pharmacogenomics and bioinformatics: PharmGKB. Pharmacogenomics 11:501–505. doi:\n                  10.2217/pgs.10.15",
      "volume": "11",
      "year": "2010"
    },
    {
      "DOI": "10.1111/j.1365-2796.2004.01328.x",
      "author": "MG Wulffele",
      "doi-asserted-by": "publisher",
      "first-page": "1",
      "journal-title": "J Intern Med",
      "key": "1647_CR62",
      "unstructured": "Wulffele MG, Kooy A, de Zeeuw D, Stehouwer CD, Gansevoort RT (2004) The effect of metformin on blood pressure, plasma cholesterol and triglycerides in type 2 diabetes mellitus: a systematic review. J Intern Med 256:1–14. doi:\n                  10.1111/j.1365-2796.2004.01328.x",
      "volume": "256",
      "year": "2004"
    },
    {
      "DOI": "10.1371/journal.pgen.1002004",
      "author": "A Zhernakova",
      "doi-asserted-by": "publisher",
      "first-page": "e1002004",
      "journal-title": "PLoS Genet",
      "key": "1647_CR63",
      "unstructured": "Zhernakova A, Stahl EA, Trynka G, Raychaudhuri S, Festen EA, Franke L, Westra HJ, Fehrmann RS, Kurreeman FA, Thomson B, Gupta N, Romanos J, McManus R, Ryan AW, Turner G, Brouwer E, Posthumus MD, Remmers EF, Tucci F, Toes R, Grandone E, Mazzilli MC, Rybak A, Cukrowska B, Coenen MJ, Radstake TR, van Riel PL, Li Y, de Bakker PI, Gregersen PK, Worthington J, Siminovitch KA, Klareskog L, Huizinga TW, Wijmenga C, Plenge RM (2011) Meta-analysis of genome-wide association studies in celiac disease and rheumatoid arthritis identifies fourteen non-HLA shared loci. PLoS Genet 7:e1002004. doi:\n                  10.1371/journal.pgen.1002004",
      "volume": "7",
      "year": "2011"
    }
  ],
  "reference-count": 63,
  "references-count": 63,
  "resource": {
    "primary": {
      "URL": "http://link.springer.com/10.1007/s00439-016-1647-9"
    }
  },
  "score": 0,
  "short-container-title": [
    "Hum Genet"
  ],
  "source": "Crossref",
  "title": [
    "Harnessing publicly available genetic data to prioritize lipid modifying therapeutic targets for prevention of coronary heart disease based on dysglycemic risk"
  ],
  "type": "journal-article",
  "update-policy": "http://dx.doi.org/10.1007/springer_crossmark_policy",
  "volume": "135"
}